Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.827 | 0.200 | 17 | 43057147 | intron variant | C/T | snv |
|
0.700 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
1.000 | 0.080 | 17 | 43083782 | intron variant | G/A | snv | 0.52 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
17 | 43125988 | intron variant | -/GTT | delins | 0.31 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
17 | 43107032 | intron variant | C/T | snv | 0.31 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
17 | 43088260 | intron variant | T/C | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
17 | 43088260 | intron variant | T/C | snv | 0.14 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.925 | 0.080 | 17 | 43086602 | intron variant | C/T | snv | 2.0E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 17 | 43086602 | intron variant | C/T | snv | 2.0E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
1.000 | 0.080 | 17 | 43078507 | intron variant | T/G | snv | 0.23 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.925 | 0.080 | 17 | 43064004 | intron variant | G/A | snv | 1.9E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 17 | 43064004 | intron variant | G/A | snv | 1.9E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||
|
0.925 | 0.080 | 17 | 43049347 | intron variant | T/C | snv | 5.5E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
0.925 | 0.080 | 17 | 43049347 | intron variant | T/C | snv | 5.5E-02 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | |||||||
|
1.000 | 0.200 | 17 | 43049216 | intron variant | AAATCACTGCAGTAA/- | delins |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
0.882 | 0.200 | 17 | 43104967 | intron variant | A/C | snv | 1.2E-05 | 7.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | |||||||||
|
0.882 | 0.200 | 17 | 43104967 | intron variant | A/C | snv | 1.2E-05 | 7.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 0 | |||||||||
|
0.827 | 0.200 | 17 | 43057147 | intron variant | C/T | snv |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.700 | 0 | |||||||||||
|
0.827 | 0.200 | 17 | 43057147 | intron variant | C/T | snv |
|
0.700 | 0 | ||||||||||||
|
0.827 | 0.200 | 17 | 43057147 | intron variant | C/T | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | |||||||||||
|
0.827 | 0.200 | 17 | 43057147 | intron variant | C/T | snv |
|
0.700 | 0 | ||||||||||||
|
1.000 | 17 | 43045842 | intron variant | A/T | snv |
|
0.700 | 0 | |||||||||||||
|
0.882 | 0.200 | 17 | 43104968 | intron variant | T/C | snv |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms | 0.700 | 0 | |||||||||||
|
0.882 | 0.200 | 17 | 43104968 | intron variant | T/C | snv |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.700 | 0 | |||||||||||
|
1.000 | 17 | 43104971 | intron variant | T/C | snv |
|
0.700 | 0 | |||||||||||||
|
0.827 | 0.200 | 17 | 43082434 | stop gained | G/A;C | snv | 2.4E-05; 3.2E-05 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Endocrine System Diseases | 0.700 | 1.000 | 28 | 1994 | 2013 |